Related references
Note: Only part of the references are listed.Prediction of Cognitive Progression in Individuals with Mild Cognitive Impairment Using Radiomics as an Improvement of the ATN System: A Five-Year Follow-Up Study
Rao Song et al.
KOREAN JOURNAL OF RADIOLOGY (2022)
Association of Initial β-Amyloid Levels With Subsequent Flortaucipir Positron Emission Tomography Changes in Persons Without Cognitive Impairment
David S. Knopman et al.
JAMA NEUROLOGY (2021)
Time course of phosphorylated-tau181 in blood across the Alzheimer's disease spectrum
Alexis Moscoso et al.
BRAIN (2021)
Head-to-head comparison of amplified plasmonic exosome Aβ42 platform and single-molecule array immunoassay in a memory clinic cohort
Tomotaka Tanaka et al.
EUROPEAN JOURNAL OF NEUROLOGY (2021)
Alzheimer's disease
Philip Scheltens et al.
LANCET (2021)
Associations of Plasma Phospho-Tau217 Levels With Tau Positron Emission Tomography in Early Alzheimer Disease
Shorena Janelidze et al.
JAMA NEUROLOGY (2021)
The Amyloid-β Pathway in Alzheimer's Disease
Harald Hampel et al.
MOLECULAR PSYCHIATRY (2021)
Prediction of future Alzheimer's disease dementia using plasma phospho-tau combined with other accessible measures
Sebastian Palmqvist et al.
NATURE MEDICINE (2021)
Developing the ATX(N) classification for use across the Alzheimer disease continuum
Harald Hampel et al.
NATURE REVIEWS NEUROLOGY (2021)
Tau-PET and in vivo Braak-staging as prognostic markers of future cognitive decline in cognitively normal to demented individuals
Davina Biel et al.
ALZHEIMERS RESEARCH & THERAPY (2021)
Optimal Combinations of AT(N) Biomarkers to Determine Longitudinal Cognition in the Alzheimer's Disease
Rong-Rong Lin et al.
FRONTIERS IN AGING NEUROSCIENCE (2021)
Prospective longitudinal atrophy in Alzheimer's disease correlates with the intensity and topography of baseline tau-PET
Renaud La Joie et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Progress in 11β-HSD1 inhibitors for the treatment of metabolic diseases: A comprehensive guide to their chemical structure diversity in drug development
Zhong Chuanxin et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling data from four cohorts
Thomas K. Karikari et al.
LANCET NEUROLOGY (2020)
Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders
Sebastian Palmqvist et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
β-amyloid and tau drive early Alzheimer's disease decline while glucose hypometabolism drives late decline
Tyler C. Hammond et al.
COMMUNICATIONS BIOLOGY (2020)
Prediction of Alzheimer's disease biomarker status defined by the 'ATN framework' among cognitively healthy individuals: results from the EPAD longitudinal cohort study
Catherine M. Calvin et al.
ALZHEIMERS RESEARCH & THERAPY (2020)
Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias
Gael Chetelat et al.
LANCET NEUROLOGY (2020)
The National Institute on Aging-Alzheimer's Association Framework on Alzheimer's disease: Application to clinical trials
Jeffrey Cummings
ALZHEIMERS & DEMENTIA (2019)
Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer's disease
Evandro F. Fang et al.
NATURE NEUROSCIENCE (2019)
A Deep Learning Model to Predict a Diagnosis of Alzheimer Disease by Using 18F-FDG PET of the Brain
Yuming Ding et al.
RADIOLOGY (2019)
A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer's disease dementia
Michael J. Pontecorvo et al.
BRAIN (2019)
Advantages and disadvantages of the use of the CSF Amyloid (A) 42/40 ratio in the diagnosis of Alzheimer's Disease
Oskar Hansson et al.
ALZHEIMERS RESEARCH & THERAPY (2019)
Frequency and longitudinal clinical outcomes of Alzheimer's AT(N) biomarker profiles: A longitudinal study
Jin-Tai Yu et al.
ALZHEIMERS & DEMENTIA (2019)
Applying the ATN scheme in a memory clinic population The ABIDE project
Daniele Altomare et al.
NEUROLOGY (2019)
Tau PET imaging in neurodegenerative tauopathies-still a challenge
Antoine Leuzy et al.
MOLECULAR PSYCHIATRY (2019)
The diagnostic performance of neurofilament light chain in CSF and blood for Alzheimer's disease, frontotemporal dementia, and amyotrophic lateral sclerosis: A systematic review and meta-analysis
Lauren M. Forgrave et al.
ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING (2019)
CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts
Oskar Hansson et al.
ALZHEIMERS & DEMENTIA (2018)
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2018)
Longitudinal tau PET in ageing and Alzheimer's disease
Clifford R. Jack et al.
BRAIN (2018)
A Decade of Blood Biomarkers for Alzheimer's Disease Research: An Evolving Field, Improving Study Designs, and the Challenge of Replication
Liu Shi et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic
Harald Hampel et al.
NATURE REVIEWS NEUROLOGY (2018)
Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer's disease
Alexandre Bejanin et al.
BRAIN (2017)
Defining imaging biomarker cut points for brain aging and Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2017)
Changes in insulin and insulin signaling in Alzheimer's disease: cause or consequence?
Molly Stanley et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
Kinetics of the Tau PET Tracer 18F-AV-1451 (T807) in Subjects with Normal Cognitive Function, Mild Cognitive Impairment, and Alzheimer Disease
Sergey Shcherbinin et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
Bob Olsson et al.
LANCET NEUROLOGY (2016)
The road to restoring neural circuits for the treatment of Alzheimer's disease
Rebecca G. Canter et al.
NATURE (2016)
MUSE: MUlti-atlas region Segmentation utilizing Ensembles of registration algorithms and parameters, and locally optimal atlas selection
Jimit Doshi et al.
NEUROIMAGE (2016)
Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression
Henrik Zetterberg et al.
JAMA NEUROLOGY (2016)
The Alzheimer's Disease Neuroimaging Initiative 2 Biomarker Core: A review of progress and plans
Ju-Hee Kang et al.
ALZHEIMERS & DEMENTIA (2015)
STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies
Patrick M. Bossuyt et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies
Patrick M. Bossuyt et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Multi-Atlas Skull-Stripping
Jimit Doshi et al.
ACADEMIC RADIOLOGY (2013)
Development and assessment of a composite score for memory in the Alzheimer's Disease Neuroimaging Initiative (ADNI)
Paul K. Crane et al.
BRAIN IMAGING AND BEHAVIOR (2012)
A composite score for executive functioning, validated in Alzheimer's Disease Neuroimaging Initiative (ADNI) participants with baseline mild cognitive impairment
Laura E. Gibbons et al.
BRAIN IMAGING AND BEHAVIOR (2012)
Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study (vol 11, pg 669, 2012)
C. M. Clark et al.
LANCET NEUROLOGY (2012)
Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study
Christopher M. Clark et al.
LANCET NEUROLOGY (2012)
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Marilyn S. Albert et al.
ALZHEIMERS & DEMENTIA (2011)
The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core
William J. Jagust et al.
ALZHEIMERS & DEMENTIA (2010)
THE INFLUENCE OF MATRIX TYPE, DIURNAL RHYTHM AND SAMPLE COLLECTION AND PROCESSING ON THE MEASUREMENT OF PLASMA β-AMYLOID ISOFORMS USING THE INNO-BIA PLASMA Aβ FORMS MULTIPLEX ASSAY
D. R. Lachno et al.
JOURNAL OF NUTRITION HEALTH & AGING (2009)
EVOLUTION OF Aβ42 AND Aβ40 LEVELS AND Aβ42/Aβ40 RATIO IN PLASMA DURING PROGRESSION OF ALZHEIMER'S DISEASE: A MULTICENTER ASSESSMENT
K. Blennow et al.
JOURNAL OF NUTRITION HEALTH & AGING (2009)
Share Paper
